Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses

Neurobiology of Aging

Volumn 24, Issue 8, 2003, Pages 1079-1085

  Mandelkow, E M ^a   Stamer, K ^a   Vogel, R ^a   Thies, E ^a   Mandelkow, E ^a  

^a MAX PLANCK UNIT FOR STRUCTURAL MOLECULAR BIOLOGY   (Germany)

Author keywords

Alzheimer's disease; Axonal traffic; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ANIMAL CELL; ANIMAL MODEL; BIOLOGICAL MODEL; BRAIN; CELL CULTURE; CELL ORGANELLE; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENT; HYPOTHESIS; METABOLISM; MICROTUBULE; MOUSE; NERVE CELL; NERVE FIBER; NERVE FIBER TRANSPORT; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; SYNAPSE; SYNAPSE VESICLE; TRANSPORT VESICLE;

EID: 0345276565     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.04.007     Document Type: Conference Paper

References (37)

1. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
2. Augustinack J.C., Schneider A., Mandelkow E.-M., Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropath. 103:2002;26-35.
3. Baas P.W. Microtubules and neuronal polarity: lessons from mitosis. Neuron. 22:1999;23-31.
4. Binder L.I., Frankfurter A., Rebhun L.I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101:1985;1371-1378.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
6. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33:2000;95-130.
7. Callahan L.M., Coleman P.D. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol. Aging. 16:1995;311-314.
8. Drewes G., Ebneth A., Mandelkow E.-M. MAPs, MARKs and microtubule dynamics. Trends Biochem. Sci. 23:1998;307-311.
9. Dringen R., Kussmaul L., Gutterer J.M., Hirrlinger J., Hamprecht B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J. Neurochem. 72:1999;2523-2530.
10. Drubin D.G., Kirschner M.W. Tau protein function in living cells. J. Cell Biol. 103:1986;2739-2746.
11. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol. 143:1998;777-794.
12. Garcia M.L., Cleveland D.W. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. Curr. Opin. Cell. Biol. 13:2001;41-48.
13. Goldstein L.S. Kinesin molecular motors: transport pathways, receptors, and human disease. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6999-7003.
14. Götz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 293:2001;1491-1495.
15. Greenfield J.P., Tsai J., Gouras G.K., Hai B., Thinakaran G., Checler F.et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 96:1999;742-747.
16. Ishihara T., Higuchi M., Zhang B., Yoshiyama Y., Hong M., Trojanowski J.Q.et al. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J. Neurosci. 21:2001;6026-6035.
17. Kaether C., Skehel P., Dotti C.G. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol. Biol. Cell. 11:2000;1213-1224.
18. Khatoon S., Grundke-Iqbal I., Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J. Neurochem. 59:1992;750-753.
19. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G.et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491.
20. Mandelkow E.-M., Mandelkow E. Tau in Alzheimer's disease. Trends Cell Biol. 8:1998;425-427.
21. Mandelkow E., Mandelkow E.-M. Kinesin motors and disease. Trends Cell Biol. 12:2002;585-591.
22. Miki H., Setou M., Kaneshiro K., Hirokawa N. All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7004-7011.
23. Morris R.L., Hollenbeck P.J. Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J. Cell Biol. 131:1995;1315-1326.
24. Novak M., Kabat J., Wischik C.M. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12:1993;365-370.
25. Raff M., Whitmore A., Finn J. Axonal self-destruction and neurodegeneration. Science. 296:2002;868-871.
26. Seitz A., Kojima H., Oiwa K., Mandelkow E.-M., Song Y.H., Mandelkow E. Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J. 21:2002;4896-4905.
27. Selkoe D. Alzheimer's disease is a synaptic failure. Science. 298:2002;789-791.
28. Shea T., Flanagan L. Kinesin, dynein and neurofilament transport. Trends Neurosci. 24:2001;644-648.
29. Simons M., Ikonen E., Tienari P.J., Cid-Arregui A., Monning U., Beyreuther K.et al. Intracellular routing of human amyloid protein precursor: axonal delivery followed by transport to the dendrites. J. Neurosci. Res. 41:1995;121-128.
30. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.-M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156:2002;1051-1063.
31. Takei Y., Teng J., Harada A., Hirokawa N. Defects in axonal elongation and neuronal migration in mice with disrupted tau and MAP1b genes. J. Cell Biol. 150:2000;989-1000.
32. Terry R.D. The cytoskeleton in Alzheimer disease. J. Neural. Transm. Suppl. 53:1998;141-145.
33. Thinakaran G., Teplow D.B., Siman R., Greenberg B., Sisodia S.S. Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a N2a cells. Evidence that cleavage at the "beta-secretase" site occurs in the Golgi apparatus. J. Biol. Chem. 271:1996;9390-9397.
34. Trinczek B., Ebneth A., Mandelkow E.-M., Mandelkow E. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell Sci. 112:1999;2355-2367.
35. von Bergen M., Friedhoff P., Biernat J., Heberle J., Mandelkow E.-M., Mandelkow E. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif 306VQIVYK311 forming beta structure. Proc. Natl. Acad. Sci. U.S.A. 97:2000;5129-5134.
36. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M.et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science. 293:2001;711-714.
37. Xu H., Sweeney D., Wang R., Thinakaran G., Lo A.C., Sisodia S.S.et al. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3748-3752.